149 results on '"Chojnacka-Wójcik, Ewa"'
Search Results
2. Synthesis and preliminary pharmacological evaluation of imidazo[2,1- f]purine-2,4-dione derivatives
3. The influence of modifications in imide fragment structure on 5-HT 1A and 5-HT 7 receptor affinity and in vivo pharmacological properties of some new 1-( m-trifluoromethylphenyl)piperazines
4. Novel class of arylpiperazines containing N-acylated amino acids: Their synthesis, 5-HT 1A, 5-HT 2A receptor affinity, and in vivo pharmacological evaluation
5. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration
6. Structure–intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT 1A receptor agents with anxiolytic- like activity
7. Anticonflict effect of the glycineB receptor partial agonist, D-cycloserine, in rats. Pharmacological analysis
8. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT 1A, 5-HT 2A, 5-HT 7), α 1-adrenergic, and dopaminergic D 2 receptors, and in vivo 5-HT 1A functional characteristics
9. Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT 1A, 5-HT 2A, and D 2 receptor activity
10. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice
11. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice
12. Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: A possible mechanism of action
13. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA A signaling
14. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABAA signaling
15. Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT1A receptors
16. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test
17. Involvement of presynaptic 5-HT1A and benzodiazepine receptors in the anticonflict activity of 5-HT1A receptor antagonists
18. The influence of substitution at aromatic part of 1,2,3,4-tetrahydroisoquinoline on in vitro and in vivo 5-HT 1A/5-HT 2A receptor activities of its 1-adamantoyloaminoalkyl derivatives
19. Synthesis and pharmacological evaluation of new arylpiperazines. 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one — a dual serotonin 5-HT 1A/5-HT 2A receptor ligand with an anxiolytic-like activity
20. New 9- or 10-arylpiperazinoalkyl substituted pyrimido- or diazepino[2,1- f]purines with partial or full 5-HT 1A agonistic activity
21. Tolerance to Anxiolytic- and Antidepressant-Like Effects of a Partial Agonist of Glycine B Receptors
22. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
23. Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity
24. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT 7 receptor antagonist in the forced swimming test in mice
25. The influence of modifications in imide fragment structure on 5-HT1A and 5-HT7 receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines
26. Novel class of arylpiperazines containing N-acylated amino acids: Their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation
27. Conformational Restriction in Novel NAN-190 and MP3022 Analogs and Their 5-HT1A Receptor Activity
28. Structure–intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity
29. Synthesis and 5-HT1A, 5-HT2A receptor activity of new β-tetralonohydantoins
30. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), α1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics
31. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action
32. Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity
33. Corrigendum to “Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor antagonist does not involve GABAA signaling” [Neuropharmacology 47 (2004) 342–350]
34. New Arylpiperazine 5-HT1A Receptor Ligands Containing the Pyrimido[2,1-f]purine Fragment: Synthesis, in Vitro, and in Vivo Pharmacological Evaluation
35. In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but not GABAA Signaling
36. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats
37. Synthesis and pharmacological evaluation of new arylpiperazines. 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one — a dual serotonin 5-HT1A/5-HT2A receptor ligand with an anxiolytic-like activity
38. Pharmacological properties and SAR of new 1,4-disubstituted piperazine derivatives with hypnotic-sedative activity
39. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors
40. The influence of substitution at aromatic part of 1,2,3,4-tetrahydroisoquinoline on in vitro and in vivo 5-HT1A/5-HT2A receptor activities of its 1-adamantoyloaminoalkyl derivatives
41. Influence of the Terminal Amide Fragment Geometry in Some 3-Arylideneindolin-2(1H)-ones on Their 5-HT1A/5-HT2A Receptor Activity
42. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
43. Anticonflict effect of the glycine B receptor partial agonist, D -cycloserine, in rats. Pharmacological analysis
44. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats
45. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models
46. On the Bioactive Conformation of NAN-190 (1) and MP3022 (2), 5-HT1A Receptor Antagonists
47. Tolerance to Anxiolytic- and Antidepressant-Like Effects of a Partial Agonist of GlycineB Receptors
48. 1,2,3,4-Tetrahydroisoquinoline Derivatives: A New Class of 5-HT 1A Receptor Ligands 1Part 34 of the series: structure–activity relationship studies of CNS agents. 1
49. New 9- or 10-arylpiperazinoalkyl substituted pyrimido- or diazepino[2,1-f]purines with partial or full 5-HT1A agonistic activity
50. Synthesis and 5-HT 1A, 5-HT 2A receptor activity of new β-tetralonohydantoins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.